tiprankstipranks
Elevation Oncology enters licensing agreement with Synaffix B.V.
PremiumThe FlyElevation Oncology enters licensing agreement with Synaffix B.V.
2M ago
Elevation Oncology presents positive Phase 1 results of EO-3021 combination
Premium
The Fly
Elevation Oncology presents positive Phase 1 results of EO-3021 combination
3M ago
Elevation Oncology’s Q3 2024 Highlights and Financial Report
Premium
Company Announcements
Elevation Oncology’s Q3 2024 Highlights and Financial Report
4M ago
Elevation Oncology reports Q2 EPS (18c), consensus (22c)
PremiumThe FlyElevation Oncology reports Q2 EPS (18c), consensus (22c)
7M ago
Elevation Oncology to evaluate combination in gastroesophageal junction cancer
Premium
The Fly
Elevation Oncology to evaluate combination in gastroesophageal junction cancer
8M ago
Elevation Oncology initiated with an Overweight at Piper Sandler
Premium
The Fly
Elevation Oncology initiated with an Overweight at Piper Sandler
9M ago
Elevation Oncology reports Q1 EPS (23c), consensus (20c)
PremiumThe FlyElevation Oncology reports Q1 EPS (23c), consensus (20c)
10M ago
Elevation Oncology presents preclinical proof-of concept data for HER3-ADC
Premium
The Fly
Elevation Oncology presents preclinical proof-of concept data for HER3-ADC
11M ago
Lori Hu Resigns, Darcy Mootz Joins Elevation Oncology Board
Premium
Company Announcements
Lori Hu Resigns, Darcy Mootz Joins Elevation Oncology Board
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100